149 related articles for article (PubMed ID: 29760795)
1. Capable Infection of Hepatitis B Virus in Diffuse Large B-cell Lymphoma.
Wang Y; Wang H; Pan S; Hu T; Shen J; Zheng H; Xie S; Xie Y; Lu R; Guo L
J Cancer; 2018; 9(9):1575-1581. PubMed ID: 29760795
[No Abstract] [Full Text] [Related]
2. Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin.
Deng L; Song Y; Young KH; Hu S; Ding N; Song W; Li X; Shi Y; Huang H; Liu W; Zheng W; Wang X; Xie Y; Lin N; Tu M; Ping L; Ying Z; Zhang C; Sun Y; Zhu J
Oncotarget; 2015 Sep; 6(28):25061-73. PubMed ID: 26314957
[TBL] [Abstract][Full Text] [Related]
3. Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma.
Zhou X; Pan H; Yang P; Ye P; Cao H; Zhou H
BMC Cancer; 2019 May; 19(1):477. PubMed ID: 31113483
[TBL] [Abstract][Full Text] [Related]
4. Role of virological serum markers in patients with both hepatitis B virus infection and diffuse large B-cell lymphoma.
Zhou X; Wuchter P; Egerer G; Kriegsmann M; Mataityte A; Koelsche C; Witzens-Harig M; Kriegsmann K
Eur J Haematol; 2019 Oct; 103(4):410-416. PubMed ID: 31338887
[TBL] [Abstract][Full Text] [Related]
5. Plasma Epstein-Barr virus and Hepatitis B virus in non-Hodgkin lymphomas: Two lymphotropic, potentially oncogenic, latently occurring DNA viruses.
Sinha M; Rao CR; Premalata CS; Shafiulla M; Lakshmaiah KC; Jacob LA; Babu GK; Viveka BK; Appaji L; Subramanyam JR
Indian J Med Paediatr Oncol; 2016; 37(3):146-51. PubMed ID: 27688607
[TBL] [Abstract][Full Text] [Related]
6. Identification of hepatitis B virus aetiologic antigens, HBx and Pre-S2, in diffuse large B-cell lymphoma.
Huang X; Young KH; Guo W; Wang Y; Wang X; Xi Y; Wang L; Bai O
J Viral Hepat; 2020 Sep; 27(9):948-950. PubMed ID: 32281709
[TBL] [Abstract][Full Text] [Related]
7. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
Ji D; Cao J; Hong X; Li J; Wang J; Chen F; Wang C; Zou S
Eur J Haematol; 2010 Sep; 85(3):243-50. PubMed ID: 20491883
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival.
Chen KL; Chen J; Rao HL; Guo Y; Huang HQ; Zhang L; Shao JY; Lin TY; Jiang WQ; Zou DH; Hu LY; Wirian ML; Cai QQ
Chin J Cancer; 2015 May; 34(5):225-34. PubMed ID: 26058465
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan.
Fwu CW; Chien YC; You SL; Nelson KE; Kirk GD; Kuo HS; Feinleib M; Chen CJ
Hepatology; 2011 Apr; 53(4):1217-25. PubMed ID: 21480326
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
[TBL] [Abstract][Full Text] [Related]
11. Clinical Analysis and Prognostic Significance of Hepatitis B Virus Infections with Diffuse Large B-Cell Lymphoma.
Kang X; Bai L; Han C; Qi X
Cancer Manag Res; 2020; 12():2839-2851. PubMed ID: 32425598
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and chemotherapy-induced reactivation of occult hepatitis B virus among hepatitis B surface antigen negative patients with diffuse large B-cell lymphoma: significance of hepatitis B core antibodies screening.
Elbedewy TA; Elashtokhy HE; Rabee ES; Kheder GE
J Egypt Natl Canc Inst; 2015 Mar; 27(1):11-8. PubMed ID: 25716703
[TBL] [Abstract][Full Text] [Related]
13. Splenic large B-cell lymphoma in patients with hepatitis C virus infection.
Takeshita M; Sakai H; Okamura S; Oshiro Y; Higaki K; Nakashima O; Uike N; Yamamoto I; Kinjo M; Matsubara F
Hum Pathol; 2005 Aug; 36(8):878-85. PubMed ID: 16112004
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus-associated B-cell non-Hodgkin lymphoma in non-endemic areas in Western Europe: Clinical characteristics and prognosis.
Lemaitre M; Brice P; Frigeni M; Hermine O; Arcaini L; Thieblemont C; Besson C
J Infect; 2020 Feb; 80(2):219-224. PubMed ID: 31846632
[TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis B virus infection is associated with a poorer prognosis in diffuse large B-cell lymphoma: a meta-analysis and systemic review.
Rong X; Wang H; Ma J; Pan S; Wang H; Jing S; Su Y; Wang L; Zhao C
J Cancer; 2019; 10(15):3450-3458. PubMed ID: 31293649
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B Virus and B-cell lymphoma: evidence, unmet need, clinical impact, and opportunities.
Rosenberg M; Poluch M; Thomas C; Sindaco P; Khoo A; Porcu P
Front Oncol; 2023; 13():1275800. PubMed ID: 37927464
[TBL] [Abstract][Full Text] [Related]
17. HBV-associated DLBCL of poor prognosis: advance in pathogenesis, immunity and therapy.
Wan X; Young KH; Bai O
Front Immunol; 2023; 14():1216610. PubMed ID: 37483605
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B infection increases the risk of non-Hodgkin lymphoma: a meta-analysis of observational studies.
Dalia S; Chavez J; Castillo JJ; Sokol L
Leuk Res; 2013 Sep; 37(9):1107-15. PubMed ID: 23809055
[TBL] [Abstract][Full Text] [Related]
19. [An analysis of hepatitis B virus infection rate in 405 cases of non-Hodgkin lymphoma].
Liu WP; Zheng W; Wang XP; Song YQ; Xie Y; Tu MF; Lin NJ; Ping LY; Ying ZT; Deng LJ; Zhang C; Zhu J
Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):521-4. PubMed ID: 22338173
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma.
Chen MH; Hsiao LT; Chiou TJ; Liu JH; Gau JP; Teng HW; Wang WS; Chao TC; Yen CC; Chen PM
Ann Hematol; 2008 Jun; 87(6):475-80. PubMed ID: 18327583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
